BETA DRUGS
Smallcap | NSE
Sector
Here's the live share price of Beta Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.57₹ 32.70
As on Sep 11, 2026, 04:08 PM IST
Source: Dion Global
Beta Drugs Price Performance
Today's LowToday's High
₹2,013.80₹2,147.80
₹2,118.50
52 Weeks' Low52 Weeks' High
₹990.10₹2,807.90
₹2,118.50
Open Price
₹2,070.00
Prev. Close
₹2,085.80
Volume
18,068
Source: Dion Global
Beta Drugs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Beta Drugs | -4.52 | -20.62 | 43.51 | 87.32 | 14.47 | 28.36 | 41.80 |
| Sun Pharmaceutical Industries | -3.08 | -5.23 | 2.58 | 0.80 | 14.34 | 17.42 | 18.72 |
| Divi's Laboratories | 2.68 | 8.92 | 40.40 | 47.09 | 55.33 | 35.74 | 12.94 |
| Torrent Pharmaceuticals | 2.10 | 1.49 | 8.46 | 11.91 | 38.38 | 38.48 | 25.98 |
| Zydus Lifesciences | 0.09 | -5.88 | 1.37 | 21.62 | 7.42 | 21.27 | 15.07 |
| Cipla | -2.23 | -7.44 | -2.11 | 1.85 | -13.24 | 2.77 | 7.34 |
| Laurus Labs | 7.28 | 6.24 | 41.93 | 89.63 | 120.41 | 69.22 | 25.04 |
| Dr. Reddy's Laboratories | 1.91 | -2.66 | -8.07 | -11.51 | -9.98 | 1.47 | 3.53 |
| Aurobindo Pharma | 1.37 | 1.07 | 14.46 | 28.43 | 51.08 | 24.53 | 17.88 |
| Lupin | -0.72 | -8.07 | -7.85 | -10.65 | 5.38 | 22.97 | 16.31 |
| Mankind Pharma | -2.48 | -6.39 | -4.32 | 1.17 | -12.65 | 8.64 | 9.80 |
| Glenmark Pharmaceuticals | -0.40 | 6.65 | 13.19 | 6.81 | 14.09 | 44.12 | 36.16 |
| Biocon | -1.48 | -8.10 | -5.88 | -0.97 | 7.54 | 12.30 | 2.06 |
| Alkem Laboratories | -1.94 | -7.92 | -4.00 | -8.21 | -5.64 | 11.92 | 5.89 |
| Abbott India | -2.13 | -8.96 | -2.13 | -6.21 | -17.64 | 3.54 | 3.60 |
| Anthem Biosciences | 0.64 | 5.43 | 20.51 | 44.90 | 14.51 | 8.78 | 5.18 |
| Ipca Laboratories | 0.16 | 12.59 | 21.99 | 28.33 | 50.02 | 29.82 | 8.68 |
| Gland Pharma | -0.27 | 0 | 26.79 | 75.43 | 48.77 | 20.17 | -5.15 |
| GlaxoSmithKline Pharmaceuticals | -4.45 | 8.63 | 34.39 | 13.69 | -1.31 | 24.62 | 12.93 |
| Ajanta Pharma | 2.03 | 0.80 | 12.46 | 15.97 | 37.44 | 26.93 | 19.93 |
Source: Dion Global
Over the last one year, Beta Drugs has gained 14.47% compared to peers like Sun Pharmaceutical Industries (14.34%), Divi's Laboratories (55.33%), Torrent Pharmaceuticals (38.38%). From a 5 year perspective, Beta Drugs has outperformed peers relative to Sun Pharmaceutical Industries (18.72%) and Divi's Laboratories (12.94%).
Beta Drugs Financials
Source: Dion Global
Beta Drugs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,169.74 | 2,150.65 |
| 10 | 2,184.76 | 2,190.22 |
| 20 | 2,282.93 | 2,242.28 |
| 50 | 2,293.56 | 2,198.53 |
| 100 | 1,914.15 | 2,012.72 |
| 200 | 1,662.38 | 1,834.23 |
Source: Dion Global
Beta Drugs Share Holding Pattern
In the latest quarter, Beta Drugs remained same as its previous close in promoter holding, while DII stake increased to 6.23%, FII holding fell to 1.02%, and public shareholding moved up to 33.65% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Beta Drugs Corporate Actions
There's no recent Announcement information to show for the company. You may visit the Beta Drugs fact sheet for more information
Source: Dion Global
About Beta Drugs
Beta Drugs Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 225.43 Cr. and Equity Capital is Rs. 10.14 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressVillage Nandpur, Baddi Himachal Pradesh 174101
- Contact
Source: Dion Global
Management
- Mr. Rahul BatraChairperson & Managing Director
- Mr. Varun BatraJoint Managing Director
- Mr. Ashutosh ShuklaWhole Time Director
- Mr. Balwant SinghWhole Time Director
- Mr. Ajay MahipalDirector
- Mr. Manmohan KhannaIndependent Director
- Mr. Rohit PartiIndependent Director
- Mrs. Monica JainIndependent Director
- Mr. Sanjay SehgalIndependent Director
- Mr. Lalit Kumar WattsIndependent Director
FAQs on Beta Drugs Share Price
What is the share price of Beta Drugs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Beta Drugs is ₹2,118.50 as on Sep 11, 2026.
What kind of stock is Beta Drugs?
The Beta Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.
What is the Market Cap of Beta Drugs?
The market cap of Beta Drugs is ₹2,361.29 Cr as on Sep 11, 2026.
What are today's High and Low prices of Beta Drugs?
Today’s highest and lowest price of Beta Drugs are ₹2,147.80 and ₹2,013.80.
What are the 52 Week High and 52 Week Low of Beta Drugs?
The 52-week high/low is the highest and lowest price at which Beta Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Beta Drugs is ₹2,807.90 and 52-week low of Beta Drugs is ₹990.10 as on Sep 11, 2026.
How has the Beta Drugs performed historically in terms of returns?
The Beta Drugs has shown returns of 1.57% over the past day, -20.6% for the past month, 43.53% over 3 months, 14.48% over 1 year, 28.36% across 3 years, and 41.8% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Beta Drugs?
P/E ratio of and PB ratio of Beta Drugs are 51.80 and 9.01 on Sep 11, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕